Phytocannabinoids modulate emotional memory processing through interactions with the ventral hippocampus and mesolimbic dopamine system: implications for neuropsychiatric pathology
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phytocannabinoids modulate emotional memory processing through interactions with the ventral hippocampus and mesolimbic dopamine system: implications for neuropsychiatric pathology
Authors
Keywords
Cannabidiol, THC, Memory, Psychosis, Rapamycin, Endocannabinoid, Emotional salience, Dopamine, Schizophrenia
Journal
PSYCHOPHARMACOLOGY
Volume 235, Issue 2, Pages 447-458
Publisher
Springer Nature
Online
2017-10-24
DOI
10.1007/s00213-017-4766-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: Implications for novel schizophrenia treatments
- (2017) Justine Renard et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Cannabidiol disrupts the reconsolidation of contextual drug-associated memories in Wistar rats
- (2016) Cristiane Ribeiro de Carvalho et al. ADDICTION BIOLOGY
- Cannabinoid Transmission in the Hippocampus Activates Nucleus Accumbens Neurons and Modulates Reward and Aversion-Related Emotional Salience
- (2016) Michael Loureiro et al. BIOLOGICAL PSYCHIATRY
- Adolescent Cannabinoid Exposure Induces a Persistent Sub-Cortical Hyper-Dopaminergic State and Associated Molecular Adaptations in the Prefrontal Cortex
- (2016) Justine Renard et al. CEREBRAL CORTEX
- Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling Pathway
- (2016) Justine Renard et al. JOURNAL OF NEUROSCIENCE
- Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors
- (2016) Raquel Linge et al. NEUROPHARMACOLOGY
- Cannabidiol Modulates Fear Memory Formation Through Interactions with Serotonergic Transmission in the Mesolimbic System
- (2016) Christopher Norris et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol, neuroprotection and neuropsychiatric disorders
- (2016) Alline C. Campos et al. PHARMACOLOGICAL RESEARCH
- AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers
- (2016) C J A Morgan et al. Translational Psychiatry
- Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose
- (2016) P Seeman Translational Psychiatry
- Cannabidiol Attenuates Sensorimotor Gating Disruption and Molecular Changes Induced by Chronic Antagonism of NMDA receptors in Mice
- (2015) Felipe V. Gomes et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Cannabidiol as a Potential Treatment for Anxiety Disorders
- (2015) Esther M. Blessing et al. Neurotherapeutics
- Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine
- (2015) J. F. C. Pedrazzi et al. PSYCHOPHARMACOLOGY
- Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol
- (2015) Felipe V. Gomes et al. SCHIZOPHRENIA RESEARCH
- A systematic review of the antipsychotic properties of cannabidiol in humans
- (2015) Tabitha A. Iseger et al. SCHIZOPHRENIA RESEARCH
- Ventral Subiculum Stimulation Promotes Persistent Hyperactivity of Dopamine Neurons and Facilitates Behavioral Effects of Cocaine
- (2015) Christelle Glangetas et al. Cell Reports
- Quantitative ultrastructural analysis of basket and axo-axonic cell terminals in the mouse hippocampus
- (2014) Virág T. Takács et al. Brain Structure & Function
- Cannabinoid Transmission in the Prefrontal Cortex Bi-Phasically Controls Emotional Memory Formation via Functional Interactions with the Ventral Tegmental Area
- (2014) B. Draycott et al. JOURNAL OF NEUROSCIENCE
- CB1 cannabinoid receptor stimulation during adolescence impairs the maturation of GABA function in the adult rat prefrontal cortex
- (2014) D K Cass et al. MOLECULAR PSYCHIATRY
- Hippocampal Cannabinoid Transmission Modulates Dopamine Neuron Activity: Impact on Rewarding Memory Formation and Social Interaction
- (2014) Michael Loureiro et al. NEUROPSYCHOPHARMACOLOGY
- Cannabinoid Modulation of Functional Connectivity within Regions Processing Attentional Salience
- (2014) Sagnik Bhattacharyya et al. NEUROPSYCHOPHARMACOLOGY
- Functional Variants in DPYSL2 Sequence Increase Risk of Schizophrenia and Suggest a Link to mTOR Signaling
- (2014) Yaping Liu et al. G3-Genes Genomes Genetics
- Infusion of cannabidiol into infralimbic cortex facilitates fear extinction via CB1 receptors
- (2013) Fabricio H. Do Monte et al. BEHAVIOURAL BRAIN RESEARCH
- The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system
- (2013) Alline C. Campos et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Is the mTOR-signalling cascade disrupted in Schizophrenia?
- (2013) Anand Gururajan et al. JOURNAL OF NEUROCHEMISTRY
- Cannabinoid Transmission in the Prelimbic Cortex Bidirectionally Controls Opiate Reward and Aversion Signaling through Dissociable Kappa Versus -Opiate Receptor Dependent Mechanisms
- (2013) T. Ahmad et al. JOURNAL OF NEUROSCIENCE
- mTOR complexes in neurodevelopmental and neuropsychiatric disorders
- (2013) Mauro Costa-Mattioli et al. NATURE NEUROSCIENCE
- Neural Primacy of the Salience Processing System in Schizophrenia
- (2013) Lena Palaniyappan et al. NEURON
- Dissociation of the Pharmacological Effects of THC by mTOR Blockade
- (2013) Emma Puighermanal et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptor activation in mice
- (2013) Felipe V. Gomes et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cannabidiol enhances consolidation of explicit fear extinction in humans
- (2013) Ravi K. Das et al. PSYCHOPHARMACOLOGY
- Definition and description of schizophrenia in the DSM-5
- (2013) Rajiv Tandon et al. SCHIZOPHRENIA RESEARCH
- Induction of Psychosis byΔ9-Tetrahydrocannabinol Reflects Modulation of Prefrontal and Striatal Function During Attentional Salience Processing
- (2012) Sagnik Bhattacharyya ARCHIVES OF GENERAL PSYCHIATRY
- Δ9-Tetrahydrocannabinol acts as a partial agonist/antagonist in mice
- (2012) Carol A. Paronis et al. BEHAVIOURAL PHARMACOLOGY
- The Yin and Yang of Cannabis-induced Psychosis: the Actions of Δ 9-Tetrahydrocannabinol and Cannabidiol in Rodent Models of Schizophrenia
- (2012) J. C. Arnold et al. CURRENT PHARMACEUTICAL DESIGN
- A Critical Review of the Antipsychotic Effects of Cannabidiol: 30 Years of a Translational Investigation
- (2012) Antonio Waldo Zuardi et al. CURRENT PHARMACEUTICAL DESIGN
- Neural Mechanisms for the Cannabinoid Modulation of Cognition and Affect in Man: A Critical Review of Neuroimaging Studies
- (2012) Sagnik Bhattacharyya et al. CURRENT PHARMACEUTICAL DESIGN
- Acute Effects of a Single, Oral dose of d9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) Administration in Healthy Volunteers
- (2012) R. Martin-Santos et al. CURRENT PHARMACEUTICAL DESIGN
- Biphasic Effects of Cannabinoids in Anxiety Responses: CB1 and GABAB Receptors in the Balance of GABAergic and Glutamatergic Neurotransmission
- (2012) Alejandro Aparisi Rey et al. NEUROPSYCHOPHARMACOLOGY
- On Disruption of Fear Memory by Reconsolidation Blockade: Evidence from Cannabidiol Treatment
- (2012) Cristina A J Stern et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview
- (2012) Giuseppe Esposito et al. PHYTOTHERAPY RESEARCH
- NMDA Receptor Hypofunction, Parvalbumin-Positive Neurons, and Cortical Gamma Oscillations in Schizophrenia
- (2012) G. Gonzalez-Burgos et al. SCHIZOPHRENIA BULLETIN
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- AKT/GSK3 signaling pathway and schizophrenia
- (2012) Effat S. Emamian Frontiers in Molecular Neuroscience
- Heterogeneity in the composition of marijuana seized in California
- (2011) James Richard Burgdorf et al. DRUG AND ALCOHOL DEPENDENCE
- Dopamine system dysregulation by the hippocampus: Implications for the pathophysiology and treatment of schizophrenia
- (2011) Anthony A. Grace NEUROPHARMACOLOGY
- Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors
- (2010) Vanessa de Paula Soares et al. BEHAVIOURAL BRAIN RESEARCH
- Processing dynamic facial affect in frequent cannabis-users: Evidence of deficits in the speed of identifying emotional expressions
- (2010) Bradley Platt et al. DRUG AND ALCOHOL DEPENDENCE
- Dopamine System Dysregulation by the Ventral Subiculum as the Common Pathophysiological Basis for Schizophrenia Psychosis, Psychostimulant Abuse, and Stress
- (2010) Anthony A. Grace NEUROTOXICITY RESEARCH
- Dopaminergic Dysfunction in Schizophrenia: Salience Attribution Revisited
- (2010) A. Heinz et al. SCHIZOPHRENIA BULLETIN
- The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes
- (2010) Helge Müller et al. SCHIZOPHRENIA RESEARCH
- Roles of the Akt/GSK-3 and Wnt Signaling Pathways in Schizophrenia and Antipsychotic Drug Action
- (2009) Zachary Freyberg et al. AMERICAN JOURNAL OF PSYCHIATRY
- High-potency cannabis and the risk of psychosis
- (2009) Marta Di Forti et al. BRITISH JOURNAL OF PSYCHIATRY
- Cannabis and psychosis/schizophrenia: human studies
- (2009) Deepak Cyril D’Souza et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Cannabis use and age of diagnosis of schizophrenia
- (2009) Gisela Sugranyes et al. EUROPEAN PSYCHIATRY
- Cannabidiol, a Nonpsychotropic Component of Cannabis, Inhibits Cue-Induced Heroin Seeking and Normalizes Discrete Mesolimbic Neuronal Disturbances
- (2009) Y. Ren et al. JOURNAL OF NEUROSCIENCE
- Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling
- (2009) Emma Puighermanal et al. NATURE NEUROSCIENCE
- Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
- (2009) Sagnik Bhattacharyya et al. NEUROPSYCHOPHARMACOLOGY
- Cannabidiol reverses the reduction in social interaction produced by low dose Δ9-tetrahydrocannabinol in rats
- (2009) Daniel Thomas Malone et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- A population-based examination of the role of years of education, age of onset, and sex on the course of schizophrenia
- (2009) Stephen Z. Levine et al. PSYCHIATRY RESEARCH
- Cannabis and psychiatric disorders: it is not only addiction
- (2008) F. Markus Leweke et al. ADDICTION BIOLOGY
- Reduced Cortical Cannabinoid 1 Receptor Messenger RNA and Protein Expression in Schizophrenia
- (2008) Stephen M. Eggan et al. ARCHIVES OF GENERAL PSYCHIATRY
- Regional Brain Abnormalities Associated With Long-term Heavy Cannabis Use
- (2008) Murat Yücel et al. ARCHIVES OF GENERAL PSYCHIATRY
- Activation of Cannabinoid-1 Receptors Disrupts Sensory Gating and Neuronal Oscillation: Relevance to Schizophrenia
- (2008) Mihály Hajós et al. BIOLOGICAL PSYCHIATRY
- Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
- (2008) J. McGrath et al. EPIDEMIOLOGIC REVIEWS
- Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum
- (2008) Matthijs G Bossong et al. NEUROPSYCHOPHARMACOLOGY
- Gene-Environment Interplay Between Cannabis and Psychosis
- (2008) C. Henquet et al. SCHIZOPHRENIA BULLETIN
- Limbic and cortical information processing in the nucleus accumbens
- (2008) Yukiori Goto et al. TRENDS IN NEUROSCIENCES
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- The orphan receptor GPR55 is a novel cannabinoid receptor
- (2007) E Ryberg et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started